Corteva, Inc.

$19.00

Want a discount? Become a member by purchasing Annual Subscription!
SKU: CTVA Category:

Description

Corteva, Inc. delivered mixed results in the quarter, with revenues below Wall Street expectations but above-par earnings. Due to the high demand for Corteva’s unique technology, its operating EBITDA margin increased by over 180 basis points in the first half of 2023, contributing to top and bottom-line growth. Pioneer and Brevant achieved double-digit revenue growth in the United States. Besides, the company introduced PowerCore, Enlist, and Advanced RA for corn to bolster its offering further. These products give farmers the flexibility of an integrated refuge as well as an advanced combination of aboveground insect management, herbicide tolerance, and market-leading genetics. This will be accessible to farmers in 2024 and strengthen the technological leadership of their top Seed brands while also opening up new prospects for out-licensing. Corteva’s Agriculture fundamentals continue to be positive. Their products remain in strong demand, and the team focuses on implementing their strategy to become more efficient. In the quarter, they also launched Reklemel active, a novel nematicide aimed at safeguarding a diverse range of food and row crops against the detrimental effects caused by plant-parasitic nematodes.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!